SCHEMBL17023657

SCHEMBL17023657

C=C(CO[Si](C)(C)C)C(=O)OCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
TSHR P16473 1/20 0.44
MAPT P10636 2/20 0.37
NPSR1 Q6W5P4 1/20 0.36
GLO1 Q04760 1/20 0.36
LMNA P02545 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ALOX15 P16050 1/20 0.34
MGAM O43451 1/20 0.34
GAA P10253 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
SOAT1 P35610 1/20 0.34
THRB P10828 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
CYP2D6 P10635 2/20 0.33
CYP2C19 P33261 1/20 0.33
XPO1 O14980 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15892856 0.83 ALDH1A1 (0.38) ALDH1A1TSHRMAPTNPSR1GLO1
SCHEMBL2219015 0.83 ALDH1A1 (0.38) ALDH1A1TSHRMAPTNPSR1GLO1
SCHEMBL1520965 0.80 ALDH1A1 (0.48) ALDH1A1TSHRMAPTNPSR1GLO1
SCHEMBL9615000 0.78 ALDH1A1 (0.47) ALDH1A1TSHRMAPTNPSR1GLO1
SCHEMBL4513312 0.78 ALDH1A1 (0.47) ALDH1A1TSHRMAPTNPSR1GLO1
SCHEMBL4087701 0.78 ALDH1A1 (0.47) ALDH1A1TSHRMAPTNPSR1GLO1
SCHEMBL23894805 0.77 THRB (0.48) ALDH1A1TSHRMAPTNPSR1GLO1
SCHEMBL2258666 0.77 ALDH1A1 (0.54) ALDH1A1TSHRMAPTNPSR1GLO1
SCHEMBL13219148 0.77 ALDH1A1 (0.46) ALDH1A1TSHRMAPTNPSR1GLO1
SCHEMBL599743 0.77 ALDH1A1 (0.45) ALDH1A1TSHRMAPTNPSR1GLO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3689338-A1 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION Oculeve, Inc. (US) 2020-08-05 EP claimed
EP-3110405-A2 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION Oculeve, Inc. (US) 2017-01-04 EP claimed
WO-2015130707-A2 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION OCULEVE, INC. (US) 2015-09-03 WO claimed
US-20150238754-A1 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION OCULEVE, INC. 2015-08-27 US claimed
WO-2021120106-A1 ALKALI-SOLUBLE RESIN, PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE ELEMENT, METHOD OF FORMING RESIST PATTERN, AND METHOD OF FORMING WIRING PATTERN SHOWA DENKO MATERIALS CO., LTD. (JP) 2021-06-24 WO disclosed
US-20210069496-A1 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION OCULEVE INC (US) 2021-03-11 US disclosed
US-10799696-B2 Polymer formulations for nasolacrimal stimulation OCULEVE, INC. (US) 2020-10-13 US disclosed
EP-3689338-A1 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION Oculeve, Inc. (US) 2020-08-05 EP disclosed
EP-3110405-B1 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION OCULEVE INC (US) 2020-05-06 EP disclosed
US-20180280688-A1 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION OCULEVE, INC. 2018-10-04 US disclosed
US-9956397-B2 Polymer Formulations for nasolacrimal stimulation OCULEVE, INC. (US) 2018-05-01 US disclosed
US-20170368333-A1 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION OCULEVE, INC. 2017-12-28 US disclosed
US-9770583-B2 Polymer formulations for nasolacrimal stimulation OCULEVE, INC. (US) 2017-09-26 US disclosed
EP-3110405-A2 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION Oculeve, Inc. (US) 2017-01-04 EP disclosed
WO-2015130707-A2 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION OCULEVE, INC. (US) 2015-09-03 WO disclosed
US-20150238754-A1 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION OCULEVE, INC. 2015-08-27 US disclosed